Mathematical assessment of different penetration mechanisms from vehicles with propylene glycol

Journal of Controlled Release

Volumn 49, Issue 2-3, 1997, Pages 141-148

  Huth, Stefan ^a   Boltze, Lothar ^a   Neubert, Reinhard ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Artificial membranes; Cotransport; Mathematical model; Penetration; Propylene glycol

Indexed keywords

BETAMETHASONE VALERATE; GLUCOCORTICOID; HYDROCORTISONE; PROPYLENE GLYCOL;

ARTICLE; ARTIFICIAL MEMBRANE; DRUG PENETRATION; DRUG SOLUBILITY; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; WATER CONTENT;

EID: 0031460353     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00066-7     Document Type: Article

References (21)

1. Yamada M., Uda Y., Tanigawara Y. Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid. Chem. Pharm. Bull. 35:1987;3399-3406.
2. Guy R.H., Hadgraft J. Prediction of drug disposition kinetics in skin and plasma following topical administration. J. Pharm. Sci. 73:1984;883-887.
3. Bendas B., Schmalfu U., Neubert R. Influence of propylene glycol as cosolvent on mechanisms of drug transport from hydrogels. Int. J. Pharm. 116:1995;19-30.
4. Mollgard B., Hoelgaard A. Vehicle effect on topical drug delivery. II. Concurrent skin transport of drugs and vehicle components. Acta Pharm Suec. 20:1983;443-450.
5. Turi J.S., Danielson D., Woltersom J.W. Effects of polyoxypropylene 15 stearyl ether and porpylene glycol on percutaneous penetration rate of diflorasone diacetate. J. Pharm. Sci. 68:1979;275-280.
6. Addicks W.J., Weiner M.D., Curl R.L., Flynn G.L. Drug delivery from topical formulations: Theoretical prediction and experimental assessment. Drugs Pharm. Sci. 42(Topical drug delivery formulations):1990;221-244.
7. Huth S., Neubert R., Boltze L., Büge A. Experimental determination and mathematical modelling of propylene glycol transport from semisolid vehicles. Chem. Pharm. Bull. 44:1996;1263-1266.
8. Friend D.R., Smedley S.I. Solvent drag in ethanol/ethyl acetate enhanced skin permeation of d-norgestrel. Int. J. Pharm. 97:1993;39-46.
9. S.I. Smedley, D. Friend, Model for ethyl acetate/ethanol skin penetration enhancement, Proc. Int. Symp. Control. Rel. Bioact. Mater. 17 (1990).
10. Ogiso T., Ito Y., Iwaki M., Atago H. A pharmacokinetic model for the percutaneous absorption of indomethacin and the prediction of drug disposition kinetics. J. Pharm. Sci. 78:1989;319-323.
11. Wallace S.W., Barnett G. Pharmacokinetic analysis of percutaneous absorption: Evidence of parallel penetration pathways for methotrexate. J. Pharmacokin. Biopharm. 6:1978;315-325.
12. Kubota K., Maibach H.I. A compartment model for percutaneous absorption: Compatibility of lag time and steady-state flux with diffusion model. J. Pharm. Sci. 81:1992;863-865.
13. H. Schwetlick, H. Kretschmar, Numerische Verfahren für Naturwissenschaftler und Ingenieure, Fachbuchverlag, Leipzig, 1991.
14. P.A. Hawley, T.R. Stevens, Two sets of benchmark problems for CSCSD packages, Proc. Third IEEE Symp. Computer-aided Control System Design, Arlington, Vol. 9 (1986).
15. Neubert R., Bendas C., Wohlrab W., Gienau B., Fürst W. A multilayer membrane system for modelling drug penetration into skin. Int. J. Pharm. 75:1991;89-94.
16. B. Bendas, Untersuchungen zum Mechanismus der in vitro-Penetration lipophiler Arzneistoffe aus binären und ternären Vehikelsystemen in künstliche und natürliche Akzeptoren, Ph.D. Thesis, Martin Luther University, Halle (Saale) 1993.
17. Lippold B. Kutane Resorption-Möglichkeiten, Modelle, Beeinflussung. Acta. Pharm. Techn. 27:1981;1-9.
18. Brunner E. Reaktionsgeschwindigkeit in heterogenen Systemen. Z. Physik. Chem. 47:1904;56-102.
19. Neubert R., Fürst W., Reppel L. Auflösungsprozesse und Oberflächenänderung, 1. Mitteilung: Mathematische Beziehungen. Pharmazie. 36:1981;128.
20. Neubert R., Fürst W. Auflösungsprozesse und Oberflächenänderung, 2. Mitteilung: Experimentelle Anwendbarkeit der abgeleiteten Gleichungen. Pharmazie. 36:1981;839.
21. Poulsen B., Young E., Katz M. Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester. J. Pharm Sci. 57:1968;928-933.